Prospective analysis of factor XI deficiencies in the Marseilles area identified four novel mutations among 12 consecutive unrelated families.
Hereditary factor XI (FXI) deficiency is an autosomal bleeding disorder of variable severity but without a clear relationship between bleeding and FXI levels or mutation location or both. In the present study, the molecular basis of FXI deficiency in 16 patients from 12 families originating from the Marseilles area in the south of France was studied. FXI defect was evidenced by routine laboratory tests showing prolonged activated partial thromboplastin times and decreased factor XI activities. The promotor region, exons 1-15, and the exon-intron boundaries of the FXI gene were sequenced. Four novel mutations were found; three were missense mutations (Cys212Ser, Gly350Arg and Thr381Leu resulting from heterozygote mutation in exon 7, 10 and 11, respectively), and one was a one base deletion in exon 4 that induces a frameshift creating a stop codon four residues later (Thr57Ile fsX4). Eight previously reported mutations were also found. Contrarily to the Jewish, Basques or Briton populations, no recurrent mutation was identified. This cohort also illustrates that bleeding events occur not exclusively and not systematically in severe FXI deficiency but also in patients characterized by a mild FXI deficiency.
Service of Medical Biology, C.H.I Poissy-St-Germain-en-Laye, Poissy, France. fquelin@chi-psg.com
Florence
F
Quélin
Corinne
C
Frère
Catherine
C
Pouymayou
Pierre
P
Morange
Philippe
P
de Mazancourt
Irène
I
Juhan-Vague
D015331:Cohort Studies; D005172:Factor XI / Q000235:genetics*; D005173:Factor XI Deficiency / Q000097:blood / Q000235:genetics*; D005260:Female; D005602:France; D006801:Humans; D008297:Male; D009154:Mutation / Q000235:genetics*; D010375:Pedigree; D011446:Prospective Studies
D005172:Factor XI